'ADVANCE' (A Pilot Trial)

NCT03858322 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cyclophosphamide
DRUG: Carboplatin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]